Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ZEISS Acquires Xradia

Published: Friday, July 19, 2013
Last Updated: Friday, July 19, 2013
Bookmark and Share
X-ray microscopy solutions close the gap between light and electron microscopy.

The closing took place on July 12, 2013 after all formal conditions, as set in the Acquisition Agreement, were fulfilled. Xradia, Inc. is now operating under the new name of Carl Zeiss X-ray Microscopy, Inc. This acquisition further strengthens the position of the ZEISS Microscopy business group, the only manufacturer of light, electron and X-ray microscopes, with unique solutions for research and routine inspection in materials and life sciences application fields.

X-ray microscopes show unique capabilities in materials research, allowing for 3D imaging of the internal structure of materials. Spatial resolution down to 50 nanometers can be achieved on a laboratory-based system. The non-destructive nature of X-ray imaging enables the observation and quantification of microstructural evolution in the same region of a single sample over time, or under changing environmental conditions. Several examples of in situ and 4D (three-dimensional imaging over time) experiments are proving beneficial for research and industry, including crack propagation in ceramics and metals, porosity and permeability characterization of geological and functional materials, failure analysis of structural materials, biomechanical systems under load, and the evolution of defects in operating lithium ion batteries and fuel cells.

X-ray microscopes close the resolution gap between light and electron microscopy and offer scientists multiple new imaging modalities to complement their research. The unique optical design allows the ZEISS Xradia Ultra and Versa series to cover a large resolution range, enabling the user to easily find the region of interest by zooming into larger samples (Scout-and-Zoom). ZEISS is working towards integrated workflow solutions for life sciences and materials research. In materials science, this is typically achieved by using X-ray microscopes to perform non-destructive 4D microstructural evolution experiments prior to destructive sectioning and then using electron microscope techniques for additional resolution and contrast. In life sciences, X-ray microscopes are being used to provide a navigational map of the subsurface after tissue samples have been stained for electron microscope investigation. By incorporating 3D X-ray microscopes into this workflow, the emerging 3D electron microscope techniques will gain a significant boost in efficiency.

While maintaining close customer relationships and continuing with current projects, ZEISS is leveraging its vast sales force to make the X-ray technology more accessible in a broader range of applications and workflows. Customers will also benefit from direct service capabilities at multiple locations globally.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

50 Years of Scanning Electron Microscopy from ZEISS
ZEISS celebrates the birth of the first commercial scanning electron microscope in 1965.
Saturday, August 08, 2015
ZEISS and UC Berkeley Launch Public-Private Partnership
Microscopy tools optimized for use with emerging neurotechnologies provided for researchers.
Saturday, June 13, 2015
ZEISS Announces Partnership with ECR Engines
Providing analytical microscopes for NASCAR Engine Producer.
Saturday, April 04, 2015
Bessel Beam Plane Illumination Microscopy Enables Fast 3D Volume Imaging
ZEISS and the Janelia Research Campus sign an exclusive license agreement for commercialization.
Tuesday, September 16, 2014
New in ZEISS Online Campus: Spectral Imaging and Fluorescence Proteins
Fluorescence microscopy training course on the Internet
Friday, October 23, 2009
Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Lab-on-a-Stick: Miniaturised Clinical Testing For Fast Detection Of Antibiotic Resistance
A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
Genetic Ancestry of Cultivated Strawberry Unravelled
UNH scientists constructed a linkage map of the seven chromosomes of the diploid Fragaria iinumae, which allows them to fill in a piece of the genetic puzzle about the eight sets of chromosomes of the cultivated strawberry.
Progress In Vaccination Against Vespid Venom
Researchers at the Helmholtz Zentrum München and the Technical University Munich have presented a method which facilitates a personalised procedure for wasp allergy sufferers.
New Drug Target for Inflammatory Disorders
Penn study finds enigmatic molecules maintain equilibrium between fighting infection and inflammatory havoc.
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Mechanisms of Calcium Blockers
Researchers describe how the fundamental mode of action of two distinct chemical classes of calcium channel blockers differs.
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!